Pediatric Endocrinology and Diabetology, Department of Pediatrics and Department of Biomedical Research, University Children's Hospital Bern, 3010, Bern, Switzerland.
Growth and Development Research Unit, Vall d'Hebron Research Institute (VHIR), Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 08035, Barcelona, Catalonia, Spain.
Eur J Hum Genet. 2018 Sep;26(9):1329-1338. doi: 10.1038/s41431-018-0202-7. Epub 2018 Jun 11.
SF-1/NR5A1 is a transcriptional regulator of adrenal and gonadal development. NR5A1 disease-causing variants cause disorders of sex development (DSD) and adrenal failure, but most affected individuals show a broad DSD/reproductive phenotype only. Most NR5A1 variants show in vitro pathogenic effects, but not when tested in heterozygote state together with wild-type NR5A1 as usually seen in patients. Thus, the genotype-phenotype correlation for NR5A1 variants remains an unsolved question. We analyzed heterozygous 46,XY SF-1/NR5A1 patients by whole exome sequencing and used an algorithm for data analysis based on selected project-specific DSD- and SF-1-related genes. The variants detected were evaluated for their significance in literature, databases and checked in silico using webtools. We identified 19 potentially deleterious variants (one to seven per patient) in 18 genes in four 46,XY DSD subjects carrying heterozygous NR5A1 disease-causing variants. We constructed a scheme of all these hits within the landscape of currently known genes involved in male sex determination and differentiation. Our results suggest that the broad phenotype in these heterozygous NR5A1 46,XY DSD subjects may well be explained by an oligogenic mode of inheritance, in which multiple hits, individually non-deleterious, may contribute to a DSD phenotype unique to each heterozygous SF-1/NR5A1 individual.
SF-1/NR5A1 是肾上腺和性腺发育的转录调节剂。NR5A1 致病变体可引起性发育障碍 (DSD) 和肾上腺功能衰竭,但大多数受影响的个体仅表现出广泛的 DSD/生殖表型。大多数 NR5A1 变体在体外具有致病性,但当与野生型 NR5A1 一起在杂合状态下测试时,如通常在患者中所见,不会表现出致病性。因此,NR5A1 变体的基因型-表型相关性仍然是一个未解决的问题。我们通过全外显子组测序分析了杂合 46,XY SF-1/NR5A1 患者,并使用基于选定的项目特异性 DSD 和 SF-1 相关基因的数据分析算法。检测到的变体在文献、数据库中进行了评估,并使用网络工具进行了计算机分析。我们在四个携带杂合 NR5A1 致病变体的 46,XY DSD 受试者中 18 个基因中发现了 19 个潜在的有害变体(每个患者一个至七个)。我们构建了一个方案,将所有这些命中物都纳入当前已知参与男性性别决定和分化的基因景观中。我们的结果表明,这些杂合 NR5A1 46,XY DSD 受试者的广泛表型很可能是由多基因遗传模式解释的,其中多个命中物,单独是非破坏性的,可能导致每个杂合 SF-1/NR5A1 个体特有的 DSD 表型。